Business Principles for Promoting Integrity in the Pharmaceutical Sector in Latin America

TI Pharmaceuticals & Healthcare is pleased to present a new set of principles focused on strengthening ethical standards across the pharmaceutical sector in Latin America, promoting integrity and ethical business practices.

Read more »

Every day, all around the world, people suffer and die due to corruption in the healthcare sector. It disproportionally affects vulnerable groups, who do not have the knowledge, money or connections to access the care or products they need.

While corruption can occur in every area of a health system, corruption from the highest levels will trickle down to effect healthcare received by patients at local health care facilities.

There are several broad effects of corruption in healthcare. Distorted policy, legislative and clinical priorities; a loss of money from health systems; denied or delayed access to health care services and treatment; and a loss of trust in national health facilities, personnel and to a wider extent national governance as a whole.

However, the specific cost of corruption is almost impossible to measure. Like other forms of white-collar crime corruption is inherently hidden from sight and even when some forms of corruption are discovered it is hard to quantify their impact.

In order to meet Sustainable Development Goal 3 that aims to ensure healthy lives and promote the wellbeing of all people of all ages, all groups in healthcare must collectively tackle corruption.

Our aim
To achieve genuine change in the pharmaceutical and healthcare sector through reducing corruption and promoting transparency, integrity and accountability

This maps the different ways that corruption has become normalised in health systems, from the politician to the patient

Health System Governance

Distorted policies and legislation will negatively affect public health goals and have a cascading effect throughout the health system.

Read more >

Health System Regulation

Regulation implemented to protect patients from the dangers of healthcare services and treatments can be exploited by individuals, companies and groups.

Read more >

Research and Development

Corruption in research and development can lead to unsafe or ineffective products entering the health system and medical knowledge being compromised.

Read more >


The improper marketing of products in the healthcare sector can lead to the use of inappropriate products and unnecessary treatments.

Read more >


Corruption in procurement can lead to the purchase of obsolete, dangerous, ineffective, or undelivered products, facilities and services.

Read more >

Product Distribution & Storage

During distribution and storage genuine products may be stolen and falsified, while substandard and re-packaged products can enter the health system.

Read more >

Financial & Workforce Management

The theft of healthcare funds and corruption in the management of healthcare providers will limit the quality of healthcare services delivered to patients.

Read more >

Delivery of Healthcare Services

Any type of corruption during the delivery of a healthcare service will directly impact on the quality and level of care offered to patients by healthcare providers.

Read more >

The Pharmaceuticals & Healthcare Programme is an international programme of Transparency International, based in the London office of Transparency International UK.

Contact Us